Core Laboratories (MEX:CLB) EBIT: MXN991 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CLB Core Laboratories Inc MEX:CLB
62 GF Score
Price MXN856.38
GF Value MXN1,333.14
! 3 Warning Signs
View Full Analysis

What is Core Laboratories EBIT?

Core Laboratories MEX:CLB 62 EBIT is MXN991 Mil as of Mar. 2026. GuruFocus rates MEX:CLB with a GF Score™ of 62/100 and a GF Value™ of MXN1,333.14. The stock has 3 warning signs investors should review.

Core Laboratories's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was MXN34 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN991 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Core Laboratories's annualized ROC % for the quarter that ended in Mar. 2026 was 0.76%. Core Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.08%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Core Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 7.57%.


Core Laboratories  (MEX:CLB) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Core Laboratories's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=89.588 * ( 1 - 25% )/( (8804.446 + 8914.52)/ 2 )
=67.191/8859.483
=0.76 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=10515.509 - 1302.298 - ( 408.765 - max(0, 1908.874 - 3865.194+408.765))
=8804.446

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=10598.323 - 1272.315 - ( 411.488 - max(0, 1888.637 - 3865.688+411.488))
=8914.52

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Core Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=136.112/( ( (2769.151 + max(1622.926, 0)) + (2789.532 + max(1658.973, 0)) )/ 2 )
=136.112/( ( 4392.077 + 4448.505 )/ 2 )
=136.112/4420.291
=3.08 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2044.151 + 981.239 + 300.137) - (1302.298 + 99.968 + 300.335)
=1622.926

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1952.527 + 1042.002 + 334.939) - (1272.315 + 84.898 + 313.282)
=1658.973

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Core Laboratories's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=990.918/13094.080
=7.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Core Laboratories EBIT Related Terms


Core Laboratories EBIT Historical Data

* Premium members only.

The historical data trend for Core Laboratories's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Core Laboratories EBIT Chart

Core Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 928.51 809.55 927.47 1,221.23 1,016.75

Core Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.36 287.92 383.91 285.07 34.03

MEX:CLB vs EROK, OIS, NGS: EBIT Comparison

For the Oil & Gas Equipment & Services subindustry, Core Laboratories's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core Laboratories EV-to-EBIT vs Oil & Gas Industry

For the Oil & Gas industry and Energy sector, Core Laboratories's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Core Laboratories's EV-to-EBIT falls into.


MEX:CLB
62GF Score
Core Laboratories Inc MEX:CLB
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Core Laboratories EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN991 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of MXN991 Mil mean?
Core Laboratories (MEX:CLB) has a EBIT of MXN991 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Core Laboratories.
Is Core Laboratories' EBIT too high?
Core Laboratories' current EBIT is MXN991 Mil. Overall, Core Laboratories has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' EBIT compare to EROK and OIS?
Core Laboratories' EBIT of MXN991 Mil can be compared against companies in the Oil & Gas industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Oil & Gas company?
A good EBIT depends on the Oil & Gas industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Core Laboratories. Core Laboratories's current EBIT is MXN991 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Core Laboratories (MEX:CLB) has a current EBIT of MXN991 Mil. The stock's GF Value™ is MXN1,333.14, compared to a current price of MXN856.38 — trading 35.8% below its estimated fair value. The current EBIT is MXN991 Mil. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Core Laboratories (MEX:CLB), the current EBIT is MXN991 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Core Laboratories (MEX:CLB) Overvalued in 2026?

Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued. The current stock price of MXN856.38 is trading 35.8% below its estimated GF Value™ of MXN1,333.14.

Key valuation signals for MEX:CLB:

  • EBIT: MXN991 Mil
  • GF Value™: MXN1,333.14 vs. price of MXN856.38 (35.8% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the MEX:CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Core Laboratories Business Description

Industry EnergyOil & Gas
Other Exchanges CLB:USAHJ1:Germany
Address 6316 Windfern Road, Houston, TX, USA, 77040
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score

Get the complete analysis for MEX:CLB

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN856.38
Price
MXN1,333.14
GF Value